Neurosciences articles for Japan

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 76

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.13
Chiral Nanoagonist Targeting EGFR for Nerve Injury Repair 0.13
1 0.25
Luminescent Detection of Photomagnetic Effect in a Near‐Infrared Emissive Neodymium(III)–Octacyanidotungstate(IV) Framework 0.25
11 1.59
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion 0.05
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis 0.24
Effects of Blood Pressure Lowering Across Hematoma Volume in Acute Intracerebral Hemorrhage: Pooled Analysis of the Four INTERACT and ATACH-2 Trials 0.04
Gelsolin‐3: A Novel Myelin Autoantigen in Demyelinating Guillain‐Barré Syndrome 0.33
Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism 0.11
CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery 0.06
Novel Aggressive Subtype of Multiple System Atrophy Identified by Unsupervised Machine Learning 0.07
Probabilistic Lesion Mapping to Optimize Thalamotomy Targets for Focal Hand Dystonia 0.42
Conditioning Electrical Stimulation for Patients with Moderate or Severe Carpal Tunnel Syndrome: Double Blinded Randomized Controlled Trial 0.17
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial 0.06
Brain Endothelial Soluble scpST2/scp Production and Cerebral Edema in a Rat Model of Ischemic Stroke 0.03
1 0.11
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment 0.11
1 1.00
Association Between a 1-Year Group-Based Telerehabilitation Program and the Quality of Life of People With Parkinson's Disease: An Observational Study 1.00
2 1.08
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study 0.08
FGL‐1 Modulates Inter‐Organ Communication by Controlling T Cell Homeostasis during the Onset of Sjögren's Disease 1.00
5 3.28
Dimethyl fumarate as a promising therapeutic candidate for virus-associated myelopathy 1.00
Natural experiment on neuroinflammatory disease incidence and infection links pre- and post-COVID-19 1.00
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study 0.01
A human striatal-midbrain assembloid model of alpha-synuclein propagation 0.26
Absence of the axon initial segment in sensory neuron enhances resistance to amyotrophic lateral sclerosis 1.00
2 0.13
IL-1R1-positive dorsal raphe neurons drive self-imposed social withdrawal in sickness 0.07
Astrocytes functionally integrate multiple synapses via specialized leaflet domains 0.06
1 1.00
Hindbrain neurons that underlie water discrimination and consumption 1.00
2 2.00
Endothelin-1 induces Zfp36 family RNA-binding proteins and restrains cytokine and chemokine production in reactive astrocytes 1.00
USP10 inhibits the degradation of α-synuclein, a pathogenic factor associated with Parkinson's disease, by inhibiting chaperone-mediated autophagy 1.00
1 0.92
The Utility of a Prediction Model Using Neurological Examination Findings for Diagnosing Degenerative Cervical Myelopathy. 0.92
1 1.00
Clinical characteristics and anti-ZSCAN1 antibody titer analysis in a nationwide survey of ROHHAD (-NET) syndrome 1.00
1 1.00
Four subtypes of disease-causing missense mutations underlie pathogenic protein interactions in neurodegenerative VPS13A disease 1.00
4 2.75
Quantifying state-dependent control properties of brain dynamics from perturbation responses 0.58
Structural plasticity of peptidergic and nonpeptidergic C afferent terminals in the medullary dorsal horn during craniofacial inflammatory pain 0.17
Common Mechanism Underlying Synaptic Dysfunction Caused by Preformed Fibril-Induced Accumulation of α-Synuclein or Tau in a Culture Propagation Model 1.00
Q Neuron-Induced Hypothermia Promotes Functional Recovery and Suppresses Neuroinflammation After Brain Injury 1.00
4 3.03
A cascade model of dynamic cerebral autoregulation 0.07
The pyrogenic mediator prostaglandin E2 elicits warmth seeking via EP3 receptor-expressing parabrachial neurons: a potential mechanism of chills 1.00
How breathing disrupts vision: hyperventilation‐induced hypocapnia impairs oculomotor responses in resting humans 1.00
Dual functions of SNAP25 in mouse taste buds 0.95
2 1.03
Femtosecond Soft X-ray Absorption Spectroscopy Identifies Metal-Centered S1 Excited State of Cyanocobalamin 0.03
A Fluorescence Microscopy Platform for Time-Resolved Studies of Spin-Correlated Radical Pairs in Biological Systems 1.00
3 0.38
An enteric neuron ionotropic receptor regulates salt stress resistance 0.23
Astrocytes enable amygdala neural representations supporting memory 0.11
Microglia–neuron crosstalk via Hex–GM2–MGL2 maintains brain homeostasis 0.05
1 0.03
Interactions with tau’s microtubule-binding repeats modulate amyloid-β aggregation and toxicity 0.03
8 5.49
Restoring early postnatal synaptic dysregulation rescues motor neuron degeneration in a mouse model of Spinal and Bulbar Muscular Atrophy 0.92
Elucidating genetic backgrounds of myasthenia gravis in Japanese by genome-wide association studies and multi-omics analyses of thymoma 1.00
Gut mucin fucosylation dictates the entry of botulinum toxin complexes 0.98
Intrinsically accelerated cellular degradation is amplified by TDP-43 loss in ALS-vulnerable motor neurons in a zebrafish model 1.00
Thalamocortical hodology to personalize electrical stimulation for focal epilepsy 0.04
SeeThrough: a rationally designed skull clearing technique for in vivo brain imaging 1.00
Mechanically robust neuroprotective stent by sequential Mg ions release for ischemic stroke therapy 0.03
Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis 0.51
1 0.02
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration 0.02
1 0.11
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.11
4 1.35
Early dopamine disruption in the entorhinal cortex of a knock-in model of Alzheimer’s disease 0.13
Adversarial AI reveals mechanisms and treatments for disorders of consciousness 0.14
Closed-loop electrical stimulation prevents focal epilepsy progression and long-term memory impairment 0.08
Noninvasive reduction of neural rigidity alters autistic behaviors in humans 1.00
1 0.06
Lcn2 from neutrophil extracellular traps induces astrogliosis and post-stroke emotional disorders 0.06
1 0.16
Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort study 0.16
5 2.49
Fatty acid regulation of feeding in Caenorhabditis elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system 0.02
High-affinity, structure-validated and selective macrocyclic peptide tools for chemical biology studies of Huntingtin 0.11
Cerebral blood flow is modulated by astrocytic cAMP elevation independently of IP3R2-mediated Ca2+ signaling in mice 0.35
S-adenosylmethionine metabolism buffering is regulated by a decrease in glycine N-methyltransferase via the nuclear ubiquitin–proteasome system 1.00
Unconventional secretion of PARK7 requires lysosomal delivery via chaperone-mediated autophagy and specialized SNARE complex 1.00
1 0.10
GPR45 modulates Gαs at primary cilia of the paraventricular hypothalamus to control food intake 0.10
4 1.55
Expansive spatial pattern of Aβ deposition in patients with cerebral amyloid angiopathy: A three-dimensional surface-to-depth analysis 1.00
Neuronal GPR75 deficiency protects against diet-induced obesity in a humanized mouse model 0.04
G proteins of the G12 family expressed by POMC neurons regulate key metabolic functions 0.07
Capturing structural intermediates in an animal-like cryptochrome photoreceptor by time-resolved crystallography 0.44
1 0.03
Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy 0.03
2 1.95
Ubiquilin-2 liquid droplets catalyze α-synuclein fibril formation. 0.95
ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation. 1.00
1 0.04
Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trials 0.04
2 0.06
Asundexian for Secondary Stroke Prevention 0.02
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1 0.05

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.